Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00496236
Status:
COMPLETED
Last Update Posted:
2012-02-23
First Post:
2007-06-28
Brief Title:
Radiotherapy Cetuximab and Injections of TNFerade Biologic for Elderly or Frail Patients With Head and Neck Cancer
Sponsor:
GenVec
Organization:
GenVec
Study Overview
Official Title:
A Phase III Safety Tolerability and Proof of Concept Study of Radiotherapy Cetuximab and Intratumoral Injections of TNFerade Biologic AdGVEGRTNF11D for Elderly or Frail Patients or Intermediate Stage Patients With Head and Neck Cancer
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is looking at the safety and tolerability of TNFeradeä Biologic combined with conventional once daily radiation therapy in elderly or frail patients with new onset locally advanced head and neck tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GV-001010 TNF-ELF | None | None | None |